Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A K Gitt

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Deutsche Medizinische Wochenschrift (1946)|March 13, 2008
[Acute intervention for ST-segment elevation myocardial infarction (STEMI): treatment in Europe]A K Gitt
Herz|November 2, 2014
[Antithrombotic treatment in patients with stable coronary artery disease. Which drugs and for how long?]A K Gitt, R Zahn
Herz|July 15, 2016
[Hypercholesterolemia - Where are we today? Where are we going?]A K Gitt, R Zahn
Herz|June 1, 2016
[Modern Lipid therapy today and tomorrow: anti-PCSK9 : A magic bullet concept following Paul Ehrlich]R Erbel, A K Gitt
Heart (British Cardiac Society)|August 22, 2001
The patient with acute myocardial infarction who does not receive reperfusion treatmentA K Gitt, J Senges
Deutsche Medizinische Wochenschrift (1946)|March 10, 2011
[Regional differences in the treatment of dyslipidemia in Germany]K Bestehorn, C Jünger, W Smolka, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 12, 2020
Collateral damage of COVID-19-lockdown in Germany: decline of NSTE-ACS admissionsA K Gitt, A K Karcher, R Zahn, et al.
Acta Diabetologica|August 5, 2015
Impact of body weight on antidiabetic treatment and predictors of weight control under real-world conditions: a 2-year follow-up of DiaRegis cohortB Hartmann, P Bramlage, S Schneider, et al.
Medizinische Klinik (Munich, Germany : 1983)|May 24, 2001
[Quality assurance in acute myocardial infarct]R Schiele, A K Gitt, H Wienbergen, et al.
Herz|April 6, 2012
[Comorbidity, hypoglycaemia and appropriate selection of antidiabetic pharmacotherapy in diabetic patients with heart failure in clinical practice in Germany. Results of the DiaRegis registry]A K Gitt, P Bramlage, C Binz, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Deutsche Medizinische Wochenschrift (1946)|March 13, 2008
[Acute intervention for ST-segment elevation myocardial infarction (STEMI): treatment in Europe]A K Gitt
Herz|November 2, 2014
[Antithrombotic treatment in patients with stable coronary artery disease. Which drugs and for how long?]A K Gitt, R Zahn
Herz|July 15, 2016
[Hypercholesterolemia - Where are we today? Where are we going?]A K Gitt, R Zahn
Herz|June 1, 2016
[Modern Lipid therapy today and tomorrow: anti-PCSK9 : A magic bullet concept following Paul Ehrlich]R Erbel, A K Gitt
Heart (British Cardiac Society)|August 22, 2001
The patient with acute myocardial infarction who does not receive reperfusion treatmentA K Gitt, J Senges
Deutsche Medizinische Wochenschrift (1946)|March 10, 2011
[Regional differences in the treatment of dyslipidemia in Germany]K Bestehorn, C Jünger, W Smolka, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 12, 2020
Collateral damage of COVID-19-lockdown in Germany: decline of NSTE-ACS admissionsA K Gitt, A K Karcher, R Zahn, et al.
Acta Diabetologica|August 5, 2015
Impact of body weight on antidiabetic treatment and predictors of weight control under real-world conditions: a 2-year follow-up of DiaRegis cohortB Hartmann, P Bramlage, S Schneider, et al.
Medizinische Klinik (Munich, Germany : 1983)|May 24, 2001
[Quality assurance in acute myocardial infarct]R Schiele, A K Gitt, H Wienbergen, et al.
Herz|April 6, 2012
[Comorbidity, hypoglycaemia and appropriate selection of antidiabetic pharmacotherapy in diabetic patients with heart failure in clinical practice in Germany. Results of the DiaRegis registry]A K Gitt, P Bramlage, C Binz, et al.
Pageof 5